Glucotrack Announces ISO 13485:2016 Certification
(NASDAQ:GCTK), RUTHERFORD, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has received ISO 13485:2016 certification from the British Standards Institute (BSI). “This ISO certification is a […]